Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Corporate Executive VP | May 29, 2020 | June 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 29, 2020 · Filed June 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 224,478 |
Reported balance
After 2020-05-29 transaction · row 1
1 source rowRow 1 · 2020-05-29 · Grant · Acquired 557 · Balance 224,478 F1: Unvested restricted stock units vest as follows: 278 on May 29, 2021 and 279 on May, 29 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested restricted stock units vest as follows: 278 on May 29, 2021 and 279 on May, 29 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 6,739 | $89.07 | $600,242.73 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 7 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,052 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $89.06 | $26,718.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 6 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,791 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $89.02 | $26,706.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 5 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,091 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 700 | $89.01 | $62,307.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 4 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,391 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 18,064 | $89.00 | $1,607,696.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 3 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,091 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 22,150 | $36.25 | $802,937.50 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 19,750 | $37.03 | $731,342.50 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 20:12 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 697 | $89.54 | $62,409.38 |
DisclosureSEC source: 0001127602-17-009168 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,255 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 20:12 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 987 | $88.05 | $86,905.35 |
DisclosureSEC source: 0001127602-17-009168 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,952 Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 13:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 1,093 | $88.05 | $96,238.65 |
DisclosureSEC source: 0001127602-17-008823 · form4.xml · nonDerivative · entry 3 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,939 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 13:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 30,847 | $0.00 Strike: $88.05 | $0.00 |
DisclosureSEC source: 0001127602-17-008823 · form4.xml · derivative · entry 4 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,847 Underlying: Common Stock · 30,847 shares Expires 2022-02-24 F3 · derivative.exercise_date: Stock options vest as follows: 7,711 options vest one (1) year from the date of grant, 7,712 options vest two (2) years from the date of grant, 7,712 options vest three (3) years from the date of grant, and 7,712 options vest four (4) years from the date of grant. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 13:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 6,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008823 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,032 F2 · security: Consists of 6,400 unvested restricted stock units that vest equally over four (4) years beginning one (1) year from the date of issuance. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 13:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008823 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,632 F1 · security: Consists of 1,208 unvested restricted stock units that vest equally over two (2) years beginning one (1) year from the date of issuance. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 13:40 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 815 | $88.40 | $72,046.00 |
DisclosureSEC source: 0001127602-17-007915 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,424 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 14:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 13,107 | $78.38 | $1,027,326.66 |
DisclosureSEC source: 0001127602-17-003437 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,239 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 14:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 29,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-003437 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,346 F1 · kind: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 28, 2014. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 13:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 13,950 | $0.00 Strike: $37.92 | $0.00 |
DisclosureSEC source: 0001127602-17-003242 · form4.xml · derivative · entry 3 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,950 shares Expires 2017-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 13:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 13,950 | $78.00 | $1,088,100.00 |
DisclosureSEC source: 0001127602-17-003242 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,746 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 13:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 13,950 | $37.92 | $528,984.00 |
DisclosureSEC source: 0001127602-17-003242 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.